HDAC6 Regulates Hsp90 Acetylation and Chaperone-Dependent Activation of Glucocorticoid Receptor

Cited by (1,001)

Items 401–500 of 1,001

1. Direct Binding with Histone Deacetylase 6 Mediates the Reversible Recruitment of Parkin to the Centrosome
   Qian Jiang, Yong Ren, Jian Feng · 2008 · Journal of Neuroscience
2. Sulforaphane reduces obesity by reversing leptin resistance
   Işın Çakır, Pauline Lining Pan, Colleen K. Hadley, Abdulrahman El-Gamal, Amina Fadel, Dina Elsayegh, Omnia Mohamed, Nasser M Rizk, Masoud Ghamari‐Langroudi · 2022 · eLife
3. IIp45 Inhibits Cell Migration through Inhibition of HDAC6
   Ying Wu, Sonya Wei Song, Jiyuan Sun, Janet M. Bruner, Gregory N. Fuller, Wei Zhang · 2009 · Journal of Biological Chemistry
4. Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat)
   Makoto Kubo, Noriko Kanaya, Karineh Petrossian, Jingjing Ye, Charles Warden, Zheng Liu, Reiki Nishimura, Tomofumi Osako, Masayuki Okido, Kazuo Shimada et al. · 2012 · Breast Cancer Research and Treatment
5. Heat shock proteins in hematopoietic malignancies
   Hajare Mjahed, François Girodon, Michaëla Fontenay, Carmen Garrido · 2012 · Experimental Cell Research
6. Explorative Study on Isoform-Selective Histone Deacetylase Inhibitors
   Takayoshi Suzuki · 2009 · Chemical and Pharmaceutical Bulletin
7. The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo
   David M Lucas, Lapo Alinari, Derek A. West, Melanie E. Davis, Ryan B. Edwards, Amy Jo Johnson, Kristie A. Blum, Craig C. Hofmeister, Michael A. Freitas, Mark R. Parthun et al. · 2010 · PLoS ONE
8. Uropathogenic Escherichia coli Invades Host Cells via an HDAC6-modulated Microtubule-dependent Pathway
   Bijaya Kumar Dhakal, Matthew A. Mulvey · 2008 · Journal of Biological Chemistry
9. Liver regeneration in aged mice: new insights
   Monica Pibiri · 2018 · Aging
10. Dysregulation of histone deacetylases in carcinogenesis and tumor progression: a possible link to apoptosis and autophagy
    Srimanta Patra, Debasna Pritimanjari Panigrahi, Prakash Priyadarshi Praharaj, Chandra Sekhar Bhol, Kewal Kumar Mahapatra, Soumya R. Mishra, Bishnu Prasad Behera, Mrutyunjay Jena, Sujit K. Bhutia · 2019 · Cellular and Molecular Life Sciences
11. A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot–Marie–Tooth disease type 1A
    Nina Ha, Young Il Choi, Namhee Jung, Ju Young Song, Dae Kwon Bae, Min Cheol Kim, Yong Jae Lee, Hyeseung Song, Geon Kwak, Soyeon Jeong et al. · 2020 · British Journal of Pharmacology
12. Requirement of histone deacetylase activity for the expression of critical photoreceptor genes
    Bo Chen, Constance L. Cepko · 2007 · BMC Developmental Biology
13. Recent Advances in Multi-target Drugs Targeting Protein Kinases and Histone Deacetylases in Cancer Therapy
    Yong Ling, Ji Liu, Jianqiang Qian, Chi Meng, Jing Guo, Weijie Gao, Biao Xiong, Chang‐Chun Ling, Yanan Zhang · 2020 · Current Medicinal Chemistry
14. The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention
    Rahma K. Alseksek, Wafaa S.H. Ramadan, Ekram Saleh, Raafat El‐Awady · 2022 · International Journal of Molecular Sciences
15. Mechanisms of Glucocorticoid-Regulated Gene Transcription
    Sebastiaan H. Meijsing · 2015 · Advances in experimental medicine and biology
16. FK228 inhibits Hsp90 chaperone function in K562 cells via hyperacetylation of Hsp70
    Ying Wang, Shengyu Wang, Xuhui Zhang, Ming Zhao, Chunmei Hou, Yuan-Ji Xu, Zhiyan Du, Xiaodan Yu · 2007 · Biochemical and Biophysical Research Communications
17. Upregulation of ABCG2 by Romidepsin via the Aryl Hydrocarbon Receptor Pathway
    Kenneth K.W. To, Robert W. Robey, Zhirong Zhan, Lois Bangiolo, Susan Elaine Bates · 2011 · Molecular Cancer Research
18. Histone deacetylase inhibitor induced modulation of anti-estrogen therapy
    Scott Thomas, Pamela N. Münster · 2009 · Cancer Letters
19. The Expression of Histone Deacetylase 1, But Not Other Class I Histone Deacetylases, Is Significantly Increased in Endometriosis
    Eleftherios Pierre Samartzis, Aurelia Noske, Nicolas Samartzis, Daniel A. Fink, Patrick Imesch · 2013 · Reproductive Sciences
20. First-in-human, Pharmacokinetic and Pharmacodynamic Phase I Study of Resminostat, an Oral Histone Deacetylase Inhibitor, in Patients with Advanced Solid Tumors
    Andre Tesainer Brunetto, Joo Ern Ang, Rohit Lal, David Olmos, L. Rhoda Molife, Rebecca Sophie Kristeleit, Ann Parker, Isabel Casamayor, Muyibat Olaleye, Anna Mais et al. · 2013 · Clinical Cancer Research
21. Proteome distribution between nucleoplasm and nucleolus and its relation to ribosome biogenesis inArabidopsis thaliana
    Denise Palm, Stefan Simm, Katrin Darm, Benjamin L. Weis, Maike Ruprecht, Enrico Schleiff, Christian Scharf · 2016 · RNA Biology
22. Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors
    Pierre Autin, Christophe Blanquart, Delphine Fradin · 2019 · Cancers
23. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors
    Wendy Anne Gold, T. A. Lacina, Laurence C. Cantrill, John Christodoulou · 2014 · Journal of Molecular Medicine
24. Epigenetic control of gene function in schistosomes: a source of therapeutic targets?
    Alejandro Cabezas‐Cruz, Julien Lancelot, Stéphanie Caby, Guilherme Oliveira, Raymond John Pierce · 2014 · Frontiers in Genetics
25. LC3B-II deacetylation by histone deacetylase 6 is involved in serum-starvation-induced autophagic degradation
    Kunpeng Liu, Dan Zhou, Dong‐Yun Ouyang, Lihui Xu, Yao Wang, Lixian Wang, Hao Pan, Xian‐Hui He · 2013 · Biochemical and Biophysical Research Communications
26. Lysine Deacetylases Regulate the Heat Shock Response Including the Age-Associated Impairment of HSF1
    Elena Zelin, Brian Freeman · 2015 · Journal of Molecular Biology
27. Heat-Shock Protein 90 Promotes Nuclear Transport of Herpes Simplex Virus 1 Capsid Protein by Interacting with Acetylated Tubulin
    Meigong Zhong, Kai Zheng, Maoyun Chen, Yangfei Xiang, Fujun Jin, Kaiqi Ma, Xianxiu Qiu, Qiao-Li Wang, Tao Peng, Kaio Kitazato et al. · 2014 · PLoS ONE
28. Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients
    Christopher Grunseich, Kristen Zukosky, Ilona R. Kats, Laboni Ghosh, George G. Harmison, Laura C. Bott, Carlo Rinaldi, Ke‐lian Chen, Guibin Chen, Manfred Boehm et al. · 2014 · Neurobiology of Disease
29. Histone Deacetylase 10 Relieves Repression on the Melanogenic Program by Maintaining the Deacetylation Status of Repressors
    I‐Lu Lai, Tung-Ping Lin, Yali Yao, Ching‐Yi Lin, Mei-Ju Hsieh, Wen‐Ming Yang · 2009 · Journal of Biological Chemistry
30. ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types
    Anderly C. Chüeh, Janson W.T. Tse, Michael John Dickinson, Paul Ioannidis, Laura J. Jenkins, Lars Tögel, BeeShin Tan, Ian Y. Luk, Mercedes Dávalos-Salas, Rebecca Nightingale et al. · 2017 · Clinical Cancer Research
31. Histone Deacetylase Inhibitors in Cancer Therapy
    Maryam Fouladi · 2006 · Cancer Investigation
32. Heat Shock Protein 90: A Unique Chemotherapeutic Target
    Sara B. Cullinan, Luke J. Whitesell · 2006 · Seminars in Oncology
33. LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway
    Hiroo Hasegawa, Yohei Yamada, Kunihiro Tsukasaki, Naoki Mori, Kazuto Tsuruda, Daisuke Sasaki, Tetsuya Usui, Akemi Osaka, Sunao Atogami, C Ishikawa et al. · 2011 · Leukemia
34. Histone deacetylase 6 gates the synaptic action of acute stress in prefrontal cortex
    Lee, Janine B., Wei, Jing, Liu, Wenhua, Cheng, Jia, Feng, Jian, Yan, Zhen · 2012 · The Journal of Physiology
35. Exciting New Targets in Lung Cancer Therapy: ALK, IGF-1R, HDAC, and Hh
    Joel W. Neal, Lecia Van Dam Sequist · 2010 · Current Treatment Options in Oncology
36. Alternative approaches to Hsp90 modulation for the treatment of cancer
    J. A. Hall, Leah K. Forsberg, B. Blagg · 2014 · Future Medicinal Chemistry
37. Therapeutic potential of selective histone deacetylase 3 inhibition
    Lihui Zhang, Yi‐Ming Chen, Qixiao Jiang, Weiguo Song, Lei Justan Zhang · 2018 · European Journal of Medicinal Chemistry
38. Coregulator Exchange and Sphingosine-Sensitive Cooperativity of Steroidogenic Factor-1, General Control Nonderepressed 5, p54, and p160 Coactivators Regulate Cyclic Adenosine 3′,5′-Monophosphate-Dependent Cytochrome P450c17 Transcription Rate
    Eric B. Dammer, Adam Leon, Marion B. Sewer · 2006 · Molecular Endocrinology
39. HDAC6 inhibition reverses long-term doxorubicin-induced cognitive dysfunction by restoring microglia homeostasis and synaptic integrity
    Blake R. McAlpin, Rajasekaran Mahalingam, Anand Kumar Singh, Shruti Dharmaraj, Taylor T. Chrisikos, Nabila Boukelmoune, Annemieke Kavelaars, Cobi J. Heijnen · 2021 · Theranostics
40. Post-translational modification of heat-shock protein 90: impact on chaperone function
    Bradley T. Scroggins, Len Neckers · 2007 · Expert Opinion on Drug Discovery
41. Epigenetics and autosomal dominant polycystic kidney disease
    Xiaogang Li · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
42. Update on molecular mechanisms of corticosteroid resistance in chronic obstructive pulmonary disease
    Zhilong Jiang, Lei Zhu · 2016 · Pulmonary Pharmacology & Therapeutics
43. Mercaptoacetamide: A promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors
    Maurício T. Tavares, Alan P. Kozikowski, Sida Shen · 2020 · European Journal of Medicinal Chemistry
44. Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase
    Jung‐Hyun Park, Hyun-Soon Jong, Sang Gyun Kim, Yeonjoo Jung, Keunwook Lee, Ju‐Hee Lee, Dae‐Kee Kim, Yung‐Jue Bang, Tae‐You Kim · 2007 · Journal of Molecular Medicine
45. Histone Deacetylase 6 Represents a Novel Drug Target in the Oncogenic Hedgehog Signaling Pathway
    Pavan Kumar Dhanyamraju, Philipp Simon Holz, Florian Finkernagel, Volker Fendrich, Matthias Lauth · 2014 · Molecular Cancer Therapeutics
46. Lysine Deacetylation by HDAC6 Regulates the Kinase Activity of AKT in Human Neural Progenitor Cells
    Jonathan Iaconelli, Jasmin Lalonde, Bradley Watmuff, Bangyan Liu, Ralph Mazitschek, Stephen J. Haggarty, Rakesh Karmacharya · 2017 · ACS Chemical Biology
47. Hsp90: From Cellular to Organismal Proteostasis
    Milán Somogyvári, Saba Khatatneh, Csaba Sőti · 2022 · Cells
48. Degradation of HIF-1alpha under Hypoxia Combined with Induction of Hsp90 Polyubiquitination in Cancer Cells by Hypericin: a Unique Cancer Therapy
    Tilda Barliya, Mathilda Mandel, Tami Livnat, Dov Weinberger, Gad Lavie · 2011 · PLoS ONE
49. Targeting histone deacetylases for the treatment of disease
    Matthew W. Lawless, Suzanne Norris, Kenneth John O'Byrne, Steven G. Gray · 2008 · Journal of Cellular and Molecular Medicine
50. Alternate Strategies of Hsp90 Modulation for the Treatment of Cancer and Other Diseases
    Gary E. L. Brandt, Brian S. J. Blagg · 2009 · Current Topics in Medicinal Chemistry
51. Management of cytoskeleton architecture by molecular chaperones and immunophilins
    Héctor Ramiro Quintá, Natalia M. Galigniana, Alejandra G. Erlejman, Mariana Lagadari, Graciela Piwien Pilipuk, Mario D. Galigniana · 2011 · Cellular Signalling
52. Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents
    Alfredo Budillon, Elena Di Gennaro, Francesca Bruzzese, Monia Rocco, G. Manzo, Michele Caraglia · 2007 · Recent Patents on Anti-Cancer Drug Discovery
53. The role of histone deacetylase 6 in synaptic plasticity and memory
    Perry, Sarah, Kiragasi, Beril, Dickman, Dion, Ray, Anandasankar · 2017 · Cell Reports
54. Histone deacetylase-6 modulates Tau function in Alzheimer's disease
    Tazeen Qureshi, Subashchandrabose Chinnathambi · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
55. A proline repeat domain in the Notch co-activator MAML1 is important for the p300-mediated acetylation of MAML1
    Mariana Saint Just Ribeiro, Magnus L. Hansson, Annika E. Wallberg · 2007 · Biochemical Journal
56. MicroRNA-433 Dampens Glucocorticoid Receptor Signaling, Impacting Circadian Rhythm and Osteoblastic Gene Expression
    Spenser S. Smith, Neha S. Dole, Tiziana Franceschetti, Henry Charles Hrdlicka, Anne M. Delany · 2016 · Journal of Biological Chemistry
57. Hsp90-dependent regulatory circuitry controlling temperature-dependent fungal development and virulence: Hsp90 and fungal development
    O'Meara, Teresa R., Cowen, Leah E. · 2014 · Cellular Microbiology
58. Activation of the Unfolded Protein Response Contributes toward the Antitumor Activity of Vorinostat
    Soumen Kahali, Bhaswati Sarcar, Bin Fang, Eli S. Williams, John M. Koomen, Philip J. Tofilon, Prakash Chinnaiyan · 2010 · Neoplasia
59. Carbamazepine promotes Her-2 protein degradation in breast cancer cells by modulating HDAC6 activity and acetylation of Hsp90
    Qingwei Meng, Xuesong Chen, Lichun Sun, Changhong Zhao, Guangjie Sui, Li Cai · 2010 · Molecular and Cellular Biochemistry
60. Epigenetic mechanisms of plant-derived anticancer drugs
    Regine Schneider‐Stock · 2011 · Frontiers in bioscience
61. New HDAC6-mediated deacetylation sites of tubulin in the mouse brain identified by quantitative mass spectrometry
    Ningning Liu, Yun Xiong, Shanshan Li, Yiran Ren, Qianqian He, Siqi Gao, Jun Zhou, Wenqing Shui · 2015 · Scientific Reports
62. Requirement of HDAC6 for activation of Notch1 by TGF-β1
    B. Deskin, Joseph A. Lasky, Yan Zhuang, Bin Shan · 2016 · Scientific Reports
63. The disordered N-terminus of HDAC6 is a microtubule-binding domain critical for efficient tubulin deacetylation
    Kseniya Ustinova, Zora Nováková, Makoto Saito, Marat Meleshin, Jana Mikesova, Zsófia Kutil, Petra Baranová, Barbora Havlínová, Mike Schutkowski, Patrick Matthias et al. · 2020 · Journal of Biological Chemistry
64. Inhibition of Histone Deacetylase (HDAC) Enhances Checkpoint Blockade Efficacy by Rendering Bladder Cancer Cells Visible for T Cell-Mediated Destruction
    Brianna Burke, Catherine Eden, Cynthia Pérez, Alex C. Belshoff, Spencer Hart, Lourdes Plaza-Rojas, Michael Delos Reyes, Kushal Prajapati, Christina Voelkel‐Johnson, Elizabeth Henry et al. · 2020 · Frontiers in Oncology
65. Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation
    Nicola Relitti, Akella Prasanth Saraswati, Giulia Chemi, Margherita Brindisi, Simone Brogi, Daniel Herp, Karin Schmidtkunz, Fulvio Saccoccia, Giovina Ruberti, Cristina Ulivieri et al. · 2020 · European Journal of Medicinal Chemistry
66. Therapeutic effects of histone deacetylase inhibitors on kidney disease
    Pusoon Chun · 2017 · Archives of Pharmacal Research
67. Metabolism, cytoskeleton and cellular signalling in the grip of protein Nϵ ‐ and O‐acetylation
    Xiang‐Jiao Yang, Serge Grégoire · 2007 · EMBO Reports
68. Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
    Mohammed I. Y. Elmallah, Olivier Micheau · 2019 · Cancers
69. Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML
    Øystein Bruserud, Camilla Stapnes, Karl Johan Tronstad, Anita Ryningen, Nina Ånensen, Bjørn Tore Gjertsen · 2006 · Expert Opinion on Therapeutic Targets
70. Notch signaling, hypoxia, and cancer
    Mingzhou Guo, Yang Niu, Min Xie, Xiansheng Liu, Xiaochen Li · 2023 · Frontiers in Oncology
71. Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program
    Hernán Carol, Richard Greg Gorlick, Edward Anders Kolb, Christopher L. Morton, Donya Moradi Manesh, Stephen Thomas Keir, C. Patrick Reynolds, Min H. Kang, John M. Maris, Amy W. Wozniak et al. · 2013 · Pediatric Blood & Cancer
72. Molecular and Biologic Analysis of Histone Deacetylase Inhibitors with Diverse Specificities
    Andrea Newbold, Geoffrey M. Matthews, Michael L Bots, Leonie A. Cluse, Christopher J.P. Clarke, Kellie-Marie Banks, Carleen M. Cullinane, Jessica E. Bolden, Ailsa J. Christiansen, Ross A. Dickins et al. · 2013 · Molecular Cancer Therapeutics
73. Effectiveness of Periodic Treatment of Quercetin against Influenza A Virus H1N1 through Modulation of Protein Expression
    Bipin Vaidya, Se‐Young Cho, Kyung-Seo Oh, Song Hak Kim, Yeong O Kim, Eun-Hye Jeong, Thoa Thi Nguyen, Sung Hyun Kim, In Seon Kim, Joseph Sang‐Il Kwon et al. · 2016 · Journal of Agricultural and Food Chemistry
74. The biological significance of histone modifiers in multiple myeloma: clinical applications
    Hiroto Ohguchi, Teru Hideshima, Kenneth Carl Anderson · 2018 · Blood Cancer Journal
75. Histone deacetylase 6 regulates cytotoxic α-synuclein accumulation through induction of the heat shock response
    Yunlan Du, Fei Wang, Jing Zou, Weidong Le, Qing Dong, Zhiying Wang, Fei Shen, Ling Yu, Yansheng Li · 2014 · Neurobiology of Aging
76. Histone deacetylases as transducers and targets of nuclear signaling
    Donald R. Walkinshaw, Soroush Tahmasebi, Nicholas Bertos, Xiang‐Jiao Yang · 2008 · Journal of Cellular Biochemistry
77. The complementation of yeast with human or Plasmodium falciparum Hsp90 confers differential inhibitor sensitivities
    Diana Wider, Marie‐Pierre Gulli, Pierre-André Briand, Utpal Shashikant Tatu, Didier Picard · 2009 · Molecular and Biochemical Parasitology
78. Epigenetic Treatment of Neurological Disease
    Steven G. Gray · 2011 · Epigenomics
79. A novel class of anthraquinone-based HDAC6 inhibitors
    Yoojin Song, Jiah Lim, Young Ho Seo · 2018 · European Journal of Medicinal Chemistry
80. An update on the emerging approaches for histone deacetylase (HDAC) inhibitor drug discovery and future perspectives
    Ma Su, Xing-Yu Gong, Feng Liu · 2021 · Expert Opinion on Drug Discovery
81. Histone deacetylase regulation of immune gene expression in tumor cells
    Anm Nazmul H. Khan, Thomas B. Tomasi · 2007 · Immunologic Research
82. S-nitrosylation of Hsp90 promotes cardiac hypertrophy in mice through GSK3β signaling
    Shuang Zhao, Tianyu Song, Ziyu Wang, Jie Gao, Jiawei Cao, Lulu Hu, Zhengrong Huang, Liping Xie, Yong Hua Ji · 2021 · Acta Pharmacologica Sinica
83. Inter-relationship of Histone Deacetylase-6 with Tau-cytoskeletal organization and remodeling
    Abhishek Ankur Balmik, Subashchandrabose Chinnathambi · 2022 · European Journal of Cell Biology
84. Regulation of Histone Deacetylase 6 Activity via S-Nitrosylation
    Kosaku Okuda, Akihiro Ito, Takashi Uehara · 2015 · Biological and Pharmaceutical Bulletin
85. Dual Inhibitors Against Topoisomerases and Histone Deacetylases
    Young Ho Seo · 2015 · Journal of Cancer Prevention
86. Heat Shock Factor 1 in Protein Homeostasis and Oncogenic Signal Integration
    Trisha Home, Roy A. Jensen, Rekha Rao · 2015 · Cancer Research
87. Chronic Mild Cold Conditioning Modulates the Expression of Hypothalamic Neuropeptide and Intermediary Metabolic-Related Genes and Improves Growth Performances in Young Chicks
    Phuong Nguyen, Elizabeth Greene, Peter Ishola, G.R. Huff, Annie M. Donoghue, Walter Gay Bottje, Sami Dridi · 2015 · PLoS ONE
88. Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis
    Chien-Yi Lu, Yi-Chih Chang, Chun-Hung Hua, Chieh Chuang, Su‐Hua Huang, Szu‐Hao Kung, Mann‐Jen Hour, Cheng‐Wen Lin · 2017 · International Journal of Molecular Sciences
89. HDAC6 Suppresses Age-Dependent Ectopic Fat Accumulation by Maintaining the Proteostasis of PLIN2 in Drosophila
    Yan Yan, Hao Wang, Minling Hu, Lifen Jiang, Yang Wang, Pingsheng Liu, Xuehong Liang, Jiyong Liu, Changqing Li, Anya Lindström Battle et al. · 2017 · Developmental Cell
90. Along the Central Dogma—Controlling Gene Expression with Small Molecules
    Tilman Schneider‐Poetsch, Minoru Yoshida · 2018 · Annual Review of Biochemistry
91. How Influenza Virus Uses Host Cell Pathways during Uncoating
    Étori Aguiar Moreira, Yohei Yamauchi, Patrick Matthias · 2021 · Cells
92. Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas
    Abraham Jacob, Janet L. Oblinger, Matthew L. Bush, Victoria J Brendel, Griffin D. Santarelli, Abhik Ray Chaudhury, Samuel Kiyota Kulp, Krista M. D. La Perle, Ching‐Shih Chen, Long‐Sheng Chang et al. · 2011 · The Laryngoscope
93. HDAC6 Is a Bruchpilot Deacetylase that Facilitates Neurotransmitter Release
    Katarzyna Miśkiewicz, Liya E. Jose, Wondwossen M Yeshaw, Jorge S. Valadas, Jef Swerts, Sebastian Munck, Fabian M. Feiguin, Bart Dermaut, Patrik Verstreken · 2014 · Cell Reports
94. Belinostat: clinical applications in solid tumors and lymphoma
    Lulama Rhoda Molife, Johann Sebastian De Bono · 2011 · Expert Opinion on Investigational Drugs
95. HDAC Inhibitors and Chaperone Function
    Rekha Rao, Warren C. Fiskus, Siddhartha Ganguly, Suman Kambhampati, Kapil N. Bhalla · 2012 · Advances in cancer research
96. Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins
    Juan Zhang, Xuefeng Gao, Li Yu · 2021 · Frontiers in Oncology
97. Curriculum vitae of HDAC6 in solid tumors
    Yi‐Chao Zheng, Huiqin Kang, Bo Wang, Yuan-Zai Zhu, MAA Mamun, Longfei Zhao, Haiqian Nie, Ying Liu, Lijuan Zhao, Xiaonan Zhang et al. · 2023 · International Journal of Biological Macromolecules
98. Endoplasmic Reticulum Stress Is Increased after Spontaneous Labor in Human Fetal Membranes and Myometrium Where It Regulates the Expression of Prolabor Mediators1
    S. Liong, M. Lappas · 2014 · Biology of Reproduction
99. Epigenetic Regulation of HIV-1 Transcription
    Manoj Kumar Tripathy, Wasim Abbas, Georges Herbein · 2011 · Epigenomics
100. Progress and prospects for targeting Hsp90 to treat fungal infections
     Amanda O. Veri, Leah E. Cowen · 2014 · Parasitology